{"id":230676,"date":"2025-06-30T00:00:00","date_gmt":"2025-06-30T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041138-medtech-neurovascular-devices-market-insights-asia\/"},"modified":"2026-03-31T10:09:39","modified_gmt":"2026-03-31T10:09:39","slug":"47042545-medtech-neurovascular-devices-market-insights-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042545-medtech-neurovascular-devices-market-insights-asia-pacific\/","title":{"rendered":"Neurovascular Devices &#8211; Market Insights &#8211; Asia Pacific"},"content":{"rendered":"<p>The Asia Pacific neurovascular device market will <span>grow strongly<\/span> through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing affordability of neurovascular procedures supported by positive clinical data. The market will see a decline in <abbr title=\"Average Selling Price\">ASP<\/abbr>s and increased price competitions, primarily driven by the impact\u00a0of <abbr data-abbreviation-entity=\"10592\" title=\"Volume-Based Procurement\">VBP<\/abbr>\u00a0in China.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurovascular devices in Asia Pacific from 2019 through 2034.<\/p>\n<p class=\"question-statement\"><strong>China\u2019s centralized procurement measures will impact the overall neurovascular device market.<\/strong><\/p>\n<p class=\"question-statement\">What are the major changes in the <abbr data-abbreviation-entity=\"8797\" title=\"Average Selling Price\">ASP<\/abbr>s of various neurovascular devices after the implementation of <abbr data-abbreviation-entity=\"10592\" title=\"Volume-Based Procurement\">VBP<\/abbr>?<\/p>\n<p class=\"question-statement\">How has the market shifted dynamically following <abbr title=\"Volume-Based Procurement\">VBP<\/abbr> implementation?<\/p>\n<p class=\"question-statement\">Which companies have gained market shares and which have been negatively impacted?<\/p>\n<p class=\"question-statement\"><strong>Emergence of evidence supporting use of embolization devices in the treatment of chronic subdural hematoma will support growth of neurovascular embolization procedure volumes.<\/strong><\/p>\n<p class=\"question-statement\">Which embolization devices will see the strongest adoption in the treatment of chronic subdural hematoma?<\/p>\n<p class=\"question-statement\">How will the uptake of embolization procedures in the treatment of chronic subdural hematoma vary across the Asia Pacific region?<\/p>\n<p class=\"question-statement\">Which companies will see market share gains?<\/p>\n<p class=\"question-statement\"><strong>The underpenetrated Indian and Chinese neurovascular device markets have strong growth potential.<\/strong><\/p>\n<p>Which factors are responsible for low penetration of neurovascular devices in India and China?<\/p>\n<p>What impact have clinical guidelines and new government initiatives had on various device segments in these countries?<\/p>\n<p>What strategies are competitors using in these markets to gain revenues?<\/p>\n<p class=\"question-statement\"><strong>N<\/strong><b>eurovascular thrombectomy devices and neurovascular embolization devices are fueling growth of overall neurovascular device market.<\/b><\/p>\n<p>What factors are driving the adoption of neurovascular thrombectomy in Australia and India?<\/p>\n<p>What is the growth outlook of these market segments in the Asia Pacific region?<\/p>\n<p>How will the uptake of these devices vary across the countries covered?<\/p>\n<p><strong>Clinical data will play an important role in driving the adoption of neurovascular devices.<\/strong><\/p>\n<p>Which clinical trials were recently conducted in this market?<\/p>\n<p>What is the expected impact of these clinical trials on the market dynamics?<\/p>\n","protected":false},"template":"","class_list":["post-230676","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-geography-asia-pacific","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/230676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/230676\/revisions"}],"predecessor-version":[{"id":486787,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/230676\/revisions\/486787"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=230676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}